Monday, October 5, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Jaspreet Kaur, MD
Hematologist-oncologist
UCSF Fresno
Published Articles (1)
Targeting Endocrine Resistance: New Sequencing Strategies in Metastatic Breast Cancer
October 3, 2026
Hormone receptor-positive, HER2-negative metastatic breast cancer that has progressed on a CDK4/6 inhibitor now has multiple biomarker-guided options